App-Quantinova.ai

D-dimer level measured at first incident cancer-related venous thromboembolism is a predictor for recurrence: a retrospective cohort study

H. Almajed - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Dealing with pediatric cancer associated thrombosis: a monocentric retrospective cohort study

E. Campello - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Decreased mitochondrial DNA copy number in patients with history of recurrent venous thromboembolism

R. Vostatek - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Deep Vein Thrombosis and Pulmonary Embolism Rates in Total Hip and Total Knee Arthroplasty Patients-A Claims Database Study

S. Simon - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Deep venous thrombosis in a child with Down syndrome as a presenting manifestation of acute lymphoblastic leukemia

A. Jovanovska - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Descriptive analysis of venous thromboembolic disease in patients under contraceptive treatment in sector III of Aragón

I. Rivas Estab�n - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Detection of hyperfunctioning platelets and novel phenotypic platelet subtypes

M. Jongen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty

B. Nemeth - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Development of an endothelialized in vitro thrombosis model with a disease relevant extracellular matrix

A. Drysdale - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Development of Consensus on Standardized Nomenclature for PT-VWD- Joint Project from the ISTH SSCs on Platelet Physiology, VWF and Genomics in thrombosis and Haemostasis

M. Othman - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Diagnostic Value Of Tromboelastography Using Korean Society On Thrombosis And Haemostasis Criteria On Disseminated Intravascular Coagulation Induced Sepsis Patients

S. Fatonah - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Differences in coagulation parameters associated with glucocorticoid treatment in patients with a first venous thrombosis: data from the MEGA study

E. Camilleri - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Glucocorticoid

Differential proteomic profile of patients with Pulmonary Embolism (PE) related to events during follow-up: chronic thromboembolic pulmonary hypertension (CTEPH) or occult cancer.

V. S�nchez L�pez - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Direct oral anticoagulant prescribing in patients with a very low bodyweight – experience from King’s College Hospital

R. Clapham - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Direct Oral Anticoagulants compared with Warfarin for the Treatment of Left Ventricular Thrombosis post Myocardial Infarction

R. Byrne - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Direct Oral Anticoagulants for Treatment of Venous Thromboembolism in Patients with Hematological Malignancies

R. Robinson - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Direct oral anticoagulants in the management of cerebral sinus vein thrombosis: A single centre experience

U. Faruqi - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Disclosing the role of endothelial dysfunction in the pathogenesis of unprovoked venous thromboembolism by using patient-specific endothelial colony-forming cells

A. Cancellara - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Disentangle the relationship between depression and arterial thrombosis associated with BDNFVal66Met polymorphism: the role of α 2-adrenergic receptor pathway

L. Sandrini - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Desipramine

Distribution of Inherited Thrombophilia Disorder and Experiences of Extremely Low Level of Protein-C: A Single-Center Study

W. AHN - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Protein C

Filters

7277 Abstracts